EUA Update: FDA Announces Intent to Withdraw Guidance
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
Fang Consulting No. 102 on Inc. Magazine’s List of Fastest-Growing Private Companies
Fang Consulting is happy to announce that after a two-year growth in revenue by 111.3%, our company ...
What to Know About De Novo
What is De Novo? The De Novo classification request provides a pathway to classify novel devices ...
What is a 510(k)?
The United States Food and Drug Administration (FDA) regulates medical devices sold in the US throug...
Public Health Emergency Expiring: What Will Happen to EUA’s?
Public Health Emergency Expiring: What Will Happen to EUA's? The COVID-19 pandemic has had a profou...
Why FDA’s Cybersecurity Draft Guidance is a Controversial Change
On April 8, 2022, the FDA released an entirely new draft guidance for premarket medical device cyber...
Post Market Clinical Follow-Up Under EU MDR
Do you wish to market your product in the EU? Well, things just got more complicated. Under the new ...
EUDAMED Timeline Update
On July 6th, 2022, the European Commission released an updated version of the EUDAMED timeline. This...
Links in the Chain: Economic Operators under MDR – Who They Are, What They Must Do… and Whether You Might Be One
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
MDR NB Common Submission Issues and How to Prevent Them
Fang’s internal processes and checklists have evolved over the last 3 years since we started working...
Questions and Answers With Maddie
If you’ve been to the office or seen the back of one of our business cards, you know that Maddie Ebe...
The Rise and Fall of the COVID-Era EUA: Why You’re Better Off with a 510(k)
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
What is a 510(k)?
The FDA generally requires manufacturers to demonstrate that a new medical device is safe and effect...
Expanded Canadian Regulatory Amendments
In December 2018, Health Canada (HC) launched the Medical Device Action Plan (MDAP). The plan is in ...
Rise of the Machines: Regulating Medical Device Software
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
Medical Devices, Medicinal Substances – and Memorex
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
Class I Devices Under MDR: To NB, Or Not To NB?
Note: The following discussion applies to non-custom, non-investigational medical devices. If you...
How Do I Know if My Software is a Medical Device?
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
The Wait is Over: What MDR Means for Your Legacy Medical Device
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
The Long and Winding Road: Regulatory Pathways for Vaccine Approvals
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
MDD to MDR – The Why, What and How of the Approaching Transition
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
Stay Calm and Carry On: What Brexit Means for Your Medical Device
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
A Look Back at the Emergency Use Authorization, and What Lies Ahead
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
Is Your Product a Medical Device? The Devil is in the Details.
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="da...
Tracy Eberly Discusses COVID-19’s Impact on Medical Device Companies
The COVID-19 health crisis has had a large impact on a plethora of sectors, with the medical device ...
